3471 - Radiation Oncology Provider Perceptions and Attitudes Towards Virtual Tumor Boards: Is Quality Maintained and Does Virtual Format Improve Work-Life Balance?
Location: Hall C
Presenter: Matt Adams, BS – Lake Erie College of Osteopathic Medicine
8:00 AM - 9:00 AM ET
3472 - A Cross Sectional Analysis of Radiation Oncology Presence on Tiktok
Location: Hall C
Presenter: Rimsha Afzal, BS – Kentucky College of Osteopathic Medicine
8:00 AM - 9:00 AM ET
3473 - Radiate & Educate: Empowering Future Physicians through an International Radiation Oncology Student Newsletter
Location: Hall C
Presenter: Anthony Alanis, BS – University of Texas Rio Grande Valley School of Medicine
8:00 AM - 9:00 AM ET
3474 - Research Match: Connecting Researchers to Projects
3475 - Quality of Life in Cervical Cancer Survivors Treated with Chemoradiotherapy: A Systematic Review
Location: Hall C
Presenter: Isabela Anawate, BA – University of Texas Southwestern Medical Center
8:00 AM - 9:00 AM ET
3476 - Standardizing Research Training in Radiation Oncology Residency: A Pilot Program Evaluation
Location: Hall C
Presenter: Rojine Ariani, MD, MS – UCLA David Geffen School of Medicine/UCLA Medical Center
8:00 AM - 9:00 AM ET
3477 - Evaluating the Impact of Bowel Gas Variations for Wilms Tumor in Pediatric Proton Therapy
Location: Hall C
Presenter: Ozgur Ates, PhD – St. Jude Children's Research Hospital
8:00 AM - 9:00 AM ET
3478 - Transforming into a Trauma-Informed Care Radiation Oncology Department: Training Program Design, Execution and Evaluation of our Programs Impact
3479 - Adjuvant Chemotherapy with High-Dose-Rate Vaginal Cuff Brachytherapy Alone vs. Chemotherapy with Pelvic Radiation (with or without Brachytherapy) in Locally Advanced Endometrial Cancer: Single Institu
3487 - Impact of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio on Definitive Treatment of Locally Advanced Cervical Cancer
Location: Hall C
Presenter: Yhana Chavis, DO – University of Virginia Health Systems
8:00 AM - 9:00 AM ET
3488 - Pilot Study of an Integrated Clinical and Didactic Interprofessional Curriculum on Breast Radiotherapy
Location: Hall C
Presenter: Jie Jane Chen, MD – University of California, San Francisco
8:00 AM - 9:00 AM ET
3489 - Efficacy of Concurrent Intensity Modulated Chemoradiotherapy Combined with Induction Chemotherapy or Adjuvant Chemotherapy in the Treatment of Locally Cervical Cancer with 2018FIGO Stage Correction
3492 - Patterns of Care and Clinical Outcomes for Pediatric Wilms Tumor Treated with Proton Therapy on the Multi-Institutional Pediatric Proton Consortium Registry
3498 - The Radiosurgery Society Mentored Publications: Advancing Guidance and Collaboration in Stereotactic Radiation Therapy while Enhancing Physician Wellness
3503 - The Role of Adjuvant Radiotherapy and Chemotherapy for Surgically Staged Non-Myoinvasive Uterine Serous Carcinoma with Negative Peritoneal Washings
Location: Hall C
Presenter: Ahmed Ghanem, MD, PhD – Henry Ford Cancer Institute/Alexandria University
8:00 AM - 9:00 AM ET
3504 - Feasibility of Biology-Guided Radiotherapy for Tumors in the Cervix Using a PET-CT Linac
3505 - Long Term Proton Therapy Outcomes in the Reirradiation Setting for Recurrent Pediatric Ependymoma
Location: Hall C
Presenter: Gobind Gill, MD – University of Alabama at Birmingham
8:00 AM - 9:00 AM ET
3506 - Incidence and Dosimetric Characteristics Associated with Mandible Osteoradionecrosis in Pediatric Patients Treated with Proton Therapy for Head and Neck Malignancies
3507 - Gavage of Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22), the Tumor Microenvironment, and Irradiation in Ovarian Cancer
Location: Hall C
Presenter: Diala Hamade, MD – University of Pittsburgh Medical Center
8:00 AM - 9:00 AM ET
3508 - Hypofractionated Pelvic Irradiation Followed by Image-Guided Brachytherapy in Women with Primary Gynecological Carcinoma or Oligometastatic Disease to Gynecological Tract: A New Paradigm of Care
Location: Hall C
Presenter: Diala Hamade, MD – University of Pittsburgh Medical Center
8:00 AM - 9:00 AM ET
3509 - Improving the Therapeutic Ratio in Parameningeal Rhabdomyosarcoma through the Use of LET-Optimized Proton Arc Therapy
3510 - Local Recurrence Rates following Equivocal 3-month Post-Treatment PET after High Dose Rate Brachytherapy for Locally Advanced Cervical Cancer: An Updated Cohort
3516 - Outcomes and Patterns of Failure for Women with FIGO Stage I-II Uterine Non-Endometroid Carcinoma after Surgical Staging, Adjuvant Chemotherapy and Vaginal Cuff Brachytherapy
Location: Hall C
Presenter: Yoonsun Jee, MD – Henry Ford Hospital-Henry Ford Cancer Institute
8:00 AM - 9:00 AM ET
3517 - Cervical Clear Cell Adenocarcinoma: Real-World Insights on Patient Profiles, Treatments and Comparative Efficacy of Locoregional Treatments
3520 - The Safety and Efficacy of Cadonilimab in the First-Line Treatment of Recurrent or Metastatic Cervical Cancer: A Retrospective, Real-World Study
Location: Hall C
Presenter: Ge Jin, PhD – The Fourth Hospital of Hebei Medical University
8:00 AM - 9:00 AM ET
3521 - Implementation of a Radiation Oncology Protocol Committee for Clinical Trial Review and Prioritization
3523 - Eight-Year Results of a Phase II Prospective Trial of Proton Therapy for Non-Metastatic Pediatric Non-Rhabdomyosarcoma Soft Tissue and Bone Sarcomas
Location: Hall C
Presenter: Soo Kang, BSN – Massachusetts General Hospital
8:00 AM - 9:00 AM ET
3524 - Human Papilloma Virus Profiles in Healthy Women, Women with Cervical Intraepithelial Neoplasia, and Women with Invasive Cervical Cancer in Botswana
3526 - Dosimetric Evaluation of a Novel HDR Brachytherapy Applicator for Intensity-Modulated Intracavitary Brachytherapy in Locally Advanced Cervical Cancers
3527 - Outcomes Following Radiation Therapy (RT) for Embryonal Tumor with Multilayered Rosettes (ETMR): Results from the Pediatric Proton/Photon Consortium Registry (PPCR)
3533 - Outcomes of Exclusive Use of Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer with a Focus on Central Control and Evaluation of an Auto-Segmentation Tool for High-Risk
3534 - Analysis of Radiation Oncology Residency Program Websites: A Call for Further Improvements
Location: Hall C
Presenter: David Lee, MD – University of Miami - Sylvester Cancer Center
8:00 AM - 9:00 AM ET
3535 - Prognostic Value of Metabolic Change in Patients with Locally Advanced Cervical Cancer Treated with Chemoradiotherapy
Location: Hall C
Presenter: Haoting Shi, MD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
8:00 AM - 9:00 AM ET
3536 - AI-Assisted 3D Printing Transvaginal Template Guidance for Interstitial Brachytherapy in Patients with Cervical Cancer with Parametrial Invasion
Location: Hall C
Presenter: Huiling Li, MD – Affiliated Hospital of Xuzhou Medical University
8:00 AM - 9:00 AM ET
3537 - Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma after External Beam Radiotherapy
3563 - Impact of Adjuvant Radiation on Mortality in Surgically Staged Stage IB Grade 3 and II Endometrioid Endometrial Cancer: Propensity Score Matching Analysis
3565 - Implementation of a Multidisciplinary Cancer Center Clinical Oncology and Research Symposium for Medical Students, Residents, Fellows and Faculty
3568 - Efficacy and Safety of Brachytherapy in Primary Vaginal Carcinoma
Location: Hall C
Presenter: Ingrid Sidibe, MD – CHU de Quebec - Universite Laval - Centre integre de cancerologie
8:00 AM - 9:00 AM ET
3569 - Pre-Treatment and Pre-Brachytherapy MRI First-Order Radiomic Features By a Commercial Software As Survival Predictors in Radiotherapy for Cervical Cancer
3573 - The Effect of Institutional Support vs. Peer Influence on Match Rates into Radiation Oncology over 5 Years: 2019 to 2023
Location: Hall C
Presenter: Olivia Trumble, BS – University of Florida College of Medicine
8:00 AM - 9:00 AM ET
3574 - Evaluation of a Graphic Narrative Patient Education Tool to Reduce Pre-Treatment Anxiety for Patients Receiving Radiotherapy in a Latin American Hospital
Location: Hall C
Presenter: Augustin Vannier, BA – University of Chicago Pritzker School of Medicine
8:00 AM - 9:00 AM ET
3575 - A Randomized Crossover Trial to Compare Two Rectum Separation Techniques during High-Dose-Rate Intracavitary Brachytherapy with Tandem-Ring Applicators for Cancer Cervix
3576 - Dosimetric Effects of Intrafraction Changes in High Dose Rate (HDR) Cervical Brachytherapy - Can We Avoid Replanning for Every Fraction in MR Guided Brachytherapy Era?
3578 - Comparing the Effects of Paclitaxel Liposomes and Albumin-Bound Paclitaxel on the Tumor Regression Rate among Cervical Cancer Patients Undergoing Concurrent Radiotherapy
Location: Hall C
Presenter: Che Wang – The First Affiliated Hospital of Xi'an Jiaotong University
8:00 AM - 9:00 AM ET
3579 - Investigation and Analysis of Nutritional Risks on Oral Nutrition Supplementation during the Peri-Radiotherapy Period: A Multicenter Cross-Sectional Study
Location: Hall C
Presenter: Cong Wang, PhD – Qilu Hospital of Shandong University
8:00 AM - 9:00 AM ET
3580 - The Association of Linear Energy Transfer and Dose with Radiation Necrosis after Proton Therapy in Pediatric Posterior Fossa Tumors
Location: Hall C
Presenter: Jarey Wang, MD, PhD – Johns Hopkins University School of Medicine
8:00 AM - 9:00 AM ET
3581 - Comprehensive Evaluation of the Prognostic Value of Hematological Parameters, Nutritional Status Indices and Serum Tumor Markers in Patients with Locally Advanced Cervical Cancer: A Retrospective Stud
3588 - Overall Experience of Two Clinical Trials for FUS-Mediated Blood Brain Barrier-Opening for Patients with DIPG/DMG Delivered in Radiation Oncology
3589 - Effects of Vertebral-Body-Sparing Proton Craniospinal Irradiation on Spinal Growth and Acute Toxicities in Pediatric Patients Using Pencil Beam Scanning
Location: Hall C
Presenter: Chuyu Xia, MD – Peking University First Hospital
8:00 AM - 9:00 AM ET
3590 - Position Selection for Postoperative Cervical Cancer Treatment with Volumetric Modulated Arc Therapy: Supine or Prone Position
Location: Hall C
Presenter: Nan Xiao, MD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
8:00 AM - 9:00 AM ET
3591 - Phase II Study of Induction Immunotherapy Combined with Platinum-Base Doublet Chemotherapy Followed by Immunotherapy and Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer
2481 - Metastasis-Directed Stereotactic Body Radiation Therapy in Oligometastatic and Oligoprogressive Solid Malignancy: Outcomes and Effect on Systemic Treatment
2484 - Incidence and Risk Factors Associated with Need for Treatment of Vertebral Compression Fractures after Spine Stereotactic Radiosurgery
Location: Hall C
Presenter: Jessica Bai, BS – Case Western Reserve School of Medicine
10:45 AM - 12:00 PM ET
2485 - Additional Salvage Spine Stereotactic Radiosurgery (SRS) Following Radiographic Progression of Spinal Metastases in Patients Previously Re-Irradiated with SRS
Location: Hall C
Presenter: Jessica Bai, BS – Case Western Reserve School of Medicine
10:45 AM - 12:00 PM ET
2486 - Progesterone Contraception and Tumor-Related Visual Impairment in Premenopausal Women with Meningioma Referred for Radiation
Location: Hall C
Presenter: Morgan Bailey, MD – University of Cincinnati - Barrett Cancer Center
10:45 AM - 12:00 PM ET
2487 - Efficacy of Stereotactic Body Radiation Therapy (SBRT) to Prolong Systemic Therapy (ST) for Patients with Oligoprogressive (OP) Metastatic Breast Cancer (MBC)
Location: Hall C
Presenter: Jose Bazan, MD, MS – City of Hope Comprehensive Cancer Center
10:45 AM - 12:00 PM ET
2488 - Impact of CT-Derived Radiomics and Dosiomics on Survival Prognosis in Glioblastoma Patients
2489 - Comparison of Distant Intracranial Disease Control between Central Nervous System-Penetrating Tyrosine Kinase Inhibitors and Immunotherapy in Non-Small Cell Lung Cancer Metastatic to Brain Following S
Location: Hall C
Presenter: Adam Beighley, MD – Kaiser Permanente Los Angeles Medical Center
10:45 AM - 12:00 PM ET
2490 - Predictors of Local Failure in the Durable Palliation of Recurrent Breast Cancer Following Concurrent Hyperthermia and High Dose Radiation
Location: Hall C
Presenter: Mark Solter, BA – Cleveland Clinic Lerner College of Medicine
10:45 AM - 12:00 PM ET
2491 - Predictors of Vertebral Compression Fracture Following Spine Stereotactic Body Radiotherapy Vary with Pre-Existing Fracture
2492 - Predictors of Vertebral Compression Fracture Following Spine Stereotactic Body Radiotherapy Vary with Cause: Iatrogenic or in Conjunction with Local Failure
2493 - Efficacy and Safety of Magnetic Resonance-Guided Online Adaptive Stereotactic Radiotherapy in Oligometastatic Gynecologic Malignancies: A Multi-Institutional Outcomes Study
2497 - Management of Multiple Brain Metastases with Serial Stereotactic Radiosurgery vs. Whole Brain Radiation Therapy
Location: Hall C
Presenter: Jie Jane Chen, MD – University of California, San Francisco
10:45 AM - 12:00 PM ET
2498 - Impact of KEAP1/NFE2L2 Mutations on Local Recurrence in Patients Receiving Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases
2507 - Characterization of Clinical Feasibility, Reproducibility and Dosimetric Impact of Palliative Immobilization Devices to Optimize Patient Comfort
2517 - Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?
2522 - Stereotactic Body Radiation Therapy vs. Palliative Radiotherapy, with or without Immunotherapy, in Metastatic Bladder Cancer: A Canadian Population Analysis
2524 - The Impact of Sequencing Checkpoint Inhibitors and Radiotherapy on Clinical Outcomes of Patients with Melanoma Brain Metastases: Meta-Analysis of Comparative Studies
2530 - Magnetic Resonance-Guided Stereotactic Body Radiotherapy for Reirradiation in the Abdomen
Location: Hall C
Presenter: Thomas Howard, MD, PhD – Mass General Brigham/Massachusetts General Hospital/Harvard Med School
10:45 AM - 12:00 PM ET
2531 - Effect of Preoperative vs. Postoperative Radiation on Leptomeningeal Disease in Treatment of Brain Metastases
Location: Hall C
Presenter: John Hoyle, MD, MS – University of Alabama Birmingham School of Medicine
10:45 AM - 12:00 PM ET
2532 - Assessing the Impact of Targeted Therapy and Immunotherapy on Clinical Outcomes in Intact Brain Metastases Treated with Stereotactic Radiosurgery - A Single Institution Experience
2540 - A Combined Phase 0/1b Trial of ATM Inhibitor AZD1390 in Combination with Radiation in Patients with Newly-Diagnosed, MGMT-Unmethylated Glioblastoma
2546 - Single-Fraction vs. Multi-fraction Stereotactic Ablative Body Radiotherapy [SBRT] for Colorectal Pulmonary Oligometastases
Location: Hall C
Presenter: Jenna Kocsis, MD – Cleveland Clinic Taussig Cancer Center
10:45 AM - 12:00 PM ET
2547 - Impact of Concurrent Antibody-Drug Conjugates and Radiotherapy on Symptomatic Radiation Necrosis in Breast Cancer Patients with Brain Metastases: A Multicenter Retrospective Study
2548 - Comparing Pain Response to Palliative Radiotherapy in Painful Bone Metastases vs. Painful Non-Bone Lesions: A Secondary Analysis of a Prospective Observational Study
2550 - Safety and Efficacy of Combination PRaG Regimen with Dynamic and Precise Regulation of Thymalfasin Dose Based on T Lymphocyte Count for the Treatment of Chemo-Refractory Metastatic Solid Tumors: An Op
2553 - Clinical Outcomes of Patients with Oligometastatic Renal Cell Cancer Treated with Stereotactic Body Radiation Therapy: Results from a Prospective Registry Trial
2554 - Genotypically-Selected Pan Cancer Trial of Camonsertib with Palliative Radiation in the Treatment of Metastatic Tumors Harboring an Ataxia-Telangiectasia Mutated (ATM) Mutation
2555 - Comparative Efficacy and Safety of Stereotactic Body Radiation Therapy Dose-Fractionation Regimens for Spinal Metastases: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Presenter: Yingying Lin, PhD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
10:45 AM - 12:00 PM ET
2559 - End of Treatment Monocyte and Lymphocyte Counts Predict for Survival over Three Years in Patients with Glioblastoma Treated with Conventional Radiation
Location: Hall C
Presenter: I-Chia Liu, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
10:45 AM - 12:00 PM ET
2560 - Quantitative Study of the Changes in the Hippocampus after Radiotherapy Via Multisequence MR Radiomics
2561 - A Pilot Study of Temporally-Modulated Pulsed Radiation Therapy to Reirradiate Recurrent IDH-Mutant Gliomas after Prior External Beam Radiation Therapy: An Interim Analysis
Location: Hall C
Presenter: Weiren Liu, MD, MS – Washington University School of Medicine in St. Louis
10:45 AM - 12:00 PM ET
2562 - Anatomic Delineation of Celiac Axis for Dosimetric Evaluation of Adaptive MRI Treatment
2564 - Utilization of Inpatient Radiation Therapy and Spine Surgery during Hospitalization for Metastatic Spinal Cord Compression
Location: Hall C
Presenter: Sifan Lu, BA – Maimonides Medical Center/SUNY Downstate HSU
10:45 AM - 12:00 PM ET
2565 - MRI Relaxometry for Glioblastoma Response Assessment during Radiation Therapy on a 0.35 T MRI Linear Accelerator
Location: Hall C
Presenter: Natalia Lutsik, MD – University of Miami Sylvester Comprehensive Cancer Center
10:45 AM - 12:00 PM ET
2566 - IKBKE, the c-myc/CSF-1 Signaling Axis, and Mediating Recruitment of M2 Tumor-Associated Macrophages (TAMs) after Radiotherapy in Glioblastoma
Location: Hall C
Presenter: Weitao Wen, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
10:45 AM - 12:00 PM ET
2567 - Stereotactic Radiotherapy Alone for Multiple Brain Metastases after Intracranial Progression in Patients with EGFR-Mutant Lung Adenocarcinoma Receiving EGFR-TKIs: A Multi-Center, Single Arm, Phase II
Location: Hall C
Presenter: Yuchao Ma, MD – Cancer Institute & Hospital Chinese Acedemy of Medical Sciences
10:45 AM - 12:00 PM ET
2568 - CDKN2A/B Alterations are Associated with Worse Prognosis in IDH Mutated 1p/19q Co-Deleted Oligodendrogliomas
2573 - Feasibility and Outcomes of Navigated Transcranial Magnetic Stimulation Based Diffusion Tensor Imaging Tractography of Motor Pathways in Patients Undergoing Stereotactic Radiosurgery
2575 - Patient Outcomes Following Palliative Hypofractionated Fast Neutron Therapy
Location: Hall C
Presenter: Ankita Menon – University of Washington
10:45 AM - 12:00 PM ET
2576 - Video Assisted Learning in Supportive Care and Improving Overall Patient PerceptioN of PALLiative Care and Clinical Trials (VISION-PALL)
Location: Hall C
Poster Presenter: C Jillian Tsai, MD, PhD, MS – Princess Margaret Cancer Centre, University Health Network, University of Toronto
Palliative Care
10:45 AM - 12:00 PM ET
2577 - Phase 2 Study of Stereotactic Body Radiation Therapy Using Intensity-Modulated Radion Therapy with Dose Escalation by Simultaneous Integrated Boost (SIB-IM-SBRT) for Spinal Metastases
2582 - Genotype and Sex Impact Memory Function after Brain Irradiation
Location: Hall C
Presenter: Jean Nakamura, MD – University of California, San Francisco
10:45 AM - 12:00 PM ET
2583 - Rib Fracture Outcomes in Patients Receiving Lung Stereotactic Body Radiotherapy
Location: Hall C
Presenter: Otasowie Odiase, MD – Kaiser Permanente Los Angeles Medical Center
10:45 AM - 12:00 PM ET
2584 - Associations between Cognitive Ability and Changes in Quality of Life among Older Adults with Metastatic Cancer Undergoing Palliative Radiation Therapy
Location: Hall C
Presenter: Amare Osei – Icahn School of Medicine at Mount Sinai
10:45 AM - 12:00 PM ET
2585 - Outcomes and Toxicities of Stereotactic Radiosurgery for Large Brainstem Metastases
Location: Hall C
Presenter: Jacob Oyeniyi, MD – Corewell Health William Beaumont University Hospital
10:45 AM - 12:00 PM ET
2586 - Early Apparent Diffusion Coefficient (ADC) Changes during Concurrent Chemoradiation (CRT): An Imaging Biomarker for Recurrence Prediction in Glioblastoma
2587 - A Prospective Survey Study of Radiation Therapy Patient Interest in Psychedelic Research
Location: Hall C
Presenter: Jino Park, MD – University of California Irvine
10:45 AM - 12:00 PM ET
2588 - Benefit of Reirradiation in Recurrent Glioblastoma after Temozolomide-Based Chemoradiation: A Secondary and Updated Analysis of the [BLINDED] Study
2590 - Pre-Operative Single Fraction vs. Fractionated Stereotactic Radiotherapy: A Single-Institution Analysis of 299 Resected Metastases
Location: Hall C
Presenter: Haley Perlow, MD – Case Western Reserve University/University Hospitals Cleveland Medical Center
10:45 AM - 12:00 PM ET
2591 - Standard Dose vs. Reduced Dose Single Fraction Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort Study
2595 - Rapid Early Progression after Surgery for IDH-Wildtype Glioblastoma and the Importance of the Pre-Radiation Planning MRI
Location: Hall C
Presenter: Jonathan Sackett, MD – University of Cincinnati - Barrett Cancer Center
10:45 AM - 12:00 PM ET
2596 - The association between time to postoperative radiotherapy, local control, and symptomatic adverse radiation effect in patients with resected brain metastases
2597 - Association of ALPS-Index and Glymphatic Flow with Neurocognitive Changes in Patients Receiving Brain Irradiation: Secondary Analysis of a Prospective Study
Location: Hall C
Presenter: Anurag Saraf, MD – Brigham and Women's Hospital/Dana-Farber
10:45 AM - 12:00 PM ET
2598 - Hypofractionated IMRT for Oligometastatic or Oligoprogressive Cancer Not Amenable to SBRT
2599 - Local and Marginal Failures in Spinal and Non-Spinal Osseous Metastases Receiving SBRT and Immunotherapy: A Secondary Analysis of Phase I Trials
2600 - Evaluating Serum CXCL Levels as Potential Biomarkers in Glioblastoma: Observed Alteration with Concurrent Chemoirradiation in Upfront Management
2607 - Occurrence of Rapid Early Progression (REP) and Rapid Early Response (RER) in Patients with Newly Diagnosed GBM Undergoing Resection and Immediate Post Resection Brachytherapy: A Preliminary Report fr
2609 - Dosimetric Comparison between Photon and Proton Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations: A Single Institution Experience
2610 - Dose Escalation with Simultaneously Integrated Boost Followed by Cyberknife Boost(SIB-CK) with BEVULTRA-100 in Newly Diagnosed Glioblastoma Multiformae (GBM): A Real World Data Analysis
2613 - Therapeutic and Prognostic Impact of Target Volume Delineation in Postoperative Radiotherapy for High-Grade Glioblastoma Patients with Subventricular Zone Involvement
2616 - Presentation and Outcomes for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Melanoma Presenting with Leptomeningeal Disease at the Time of Initial Central Nervous System Involvement
Location: Hall C
Presenter: Ryan Tang, BA – University of South Florida College of Medicine
10:45 AM - 12:00 PM ET
2617 - Prospective Study of All Sensations Patients Experience While Proton or Photon External Beams Are on
2618 - Risk of Radiation Necrosis after Stereotactic Radiosurgery with and without Immune Checkpoint Inhibition in Patients with NSCLC Brain Metastases in Eloquent Locations
2619 - Long-Term Outcomes of Single-Fraction Stereotactic Ablative Radiotherapy (SAbR) Using a Simultaneous-Integrated Boost (SIB) Approach for the Treatment of de Novo Spinal Metastases
2622 - Postoperative Treatment for Metastatic Brain Metastases from Non-Small Cell Lung Cancer after Intracranial Tumor Resection: A Multi-Institutional Retrospective Study
Location: Hall C
Presenter: Megumi Uto, MD, PhD – Kyoto University Graduate School of Medicine
10:45 AM - 12:00 PM ET
2623 - Patterns of Care of Brain Metastasis for Non-Small Cell Lung Cancer (NSCLC) in the Era of Immunotherapy
2624 - Clinical Outcomes of Stereotactic Body Radiotherapy for Spinal Metastases with Paraspinal Extension
Location: Hall C
Presenter: Neil Vuppala, BA – Alabama College of Osteopathic Medicine
10:45 AM - 12:00 PM ET
2625 - Radiotherapy Combined with Pyrotinib Plus Capecitabine in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer and Brain Metastases: A Single-Arm, Exploratory Trial
2626 - Postoperative Radiotherapy for Malignant Cord Compression Treated in a Public and Private Hospital
Location: Hall C
Presenter: Jonathan Wang, BS – University of Southern California Keck School of Medicine
10:45 AM - 12:00 PM ET
2627 - Spatially Fractionated Radiotherapy GRID for Bulky Tumor: A Large Single Institution Experience
Location: Hall C
Presenter: Kaidi Wang, MD – University of Arkansas for Medical Sciences (UAMS)
10:45 AM - 12:00 PM ET
2628 - Prediction Study of Prognostic Nutrition Index on the Nausea and Vomiting of Patients with Cancer Undergoing Chemotherapy or Concurrent Chemoradiotherapy Based on Cisplatin
2632 - Biological Effective Dose-Based Fractionated Stereotactic Radiation Therapy for Brain Metastasis in the New Era: A Retrospective Multi-Institution Study
2634 - A Pilot Phase 2 Study Evaluating Dose De-Escalation in Whole Brain Radiation Therapy with Simultaneous Integrated Boost for Patients with Brain Metastases
2635 - Radiation Dose Fractionations for Malignant Spinal Cord Compression in Patients Not Eligible for Surgery: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
2635 - Radiation Dose Fractionations for Malignant Spinal Cord Compression in Patients Not Eligible for Surgery: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Location: Hall C
Presenter: Henry Wong, MBBS – Princess Margaret Hospital Hong Kong
10:45 AM - 12:00 PM ET
2636 - Can Individualized Dosimetry Improve Treatment Efficacy for 177Lu-DOTATATE (D) Therapy in Primary Site Agnostic Neuroendocrine Tumors?
2639 - Modeling of Out-of-Pocket Costs across Medicaid and Medicare Plans of Standard-of-Care External Beam Radiation Therapy vs. Radiosurgery for Symptomatic Metastatic Spine Cancer
Location: Hall C
Presenter: Victoria Wu, BA – Case Western Reserve School of Medicine
10:45 AM - 12:00 PM ET
2640 - Modeling of Out-Of-Pocket Costs Across Medicaid and Medicare Plans of Standard-of-Care Radiosurgery Duration for Metastatic Spine Cancer
Location: Hall C
Presenter: Victoria Wu, BA – Case Western Reserve School of Medicine
10:45 AM - 12:00 PM ET
2641 - Whole-Brain Radiation Therapy with Simultaneous Integrated Boost vs. Stereotactic Radiotherapy for the Treatment of Brain Metastasis from Non-Small Cell Lung Cancer
2647 - MDM2 Inhibition and the Efficacy of Radiotherapy and PD-L1 Antibody Combination Therapy by Reprogramming the Glioblastoma Tumor Microenvironment
2648 - Prognostic Factors for Local Failure and Overall Survival in Patients with Epidural Disease at the Cauda Equina Following Stereotactic Body Radiotherapy: A Clinical, Anatomic and Dosimetric Analysis
2649 - Stereotactic Radiotherapy vs. Whole Brain Radiation Therapy in EGFR Mutated NSCLC: Results and Reflections from the Prematurely Closed Phase III HYBRID Trial
2654 - Over Treatment of Stage I, Node-Negative, Hormone-Sensitive Breast Cancer? Analysis of Techniques and Doses at a Comprehensive Cancer Center with Community Network Affiliates
Location: Hall C
Presenter: Jose Bazan, MD, MS – City of Hope Comprehensive Cancer Center
3:00 PM - 4:00 PM ET
2656 - Smoking History and Breast Shrinkage Following Breast Conserving Treatment and Radiation Therapy
2657 - Comparison between Proton LET-Dependent RBE Dose and Photon Physical Dose for Acute Radiation Dermatitis in Caucasian and African-American Breast Cancer Patients Undergoing Radiation Therapy
2664 - Cardiopulmonary Substructure Doses are Not Correlated with Cardiorespiratory Fitness among Breast Cancer Survivors Treated with Contemporary Radiotherapy
2669 - Photon vs. Proton Post-Mastectomy Radiotherapy Toxicities in Pre-Pectoral Implant-Based Breast Reconstruction
Location: Hall C
Presenter: Seraphina Choi, MD – University of Miami Miller School of Medicine
3:00 PM - 4:00 PM ET
2670 - Stereotactic Radiotherapy (SRT) with Maintenance Systemic Therapy vs. Standard-of-Care (SOC) Systemic Therapy for Oligoprogressive ER-Positive, HER2-Negative Breast Cancer (AVATAR II)
2678 - Safety of Concurrent Administration of TDM1 and Radiotherapy in Patients with HER2+ Breast Cancer with Residual Disease Post-Neoadjuvant Chemotherapy
2680 - Long Term Single Institution Clinical Outcomes for Locally Recurrent Breast Cancer Patients Treated with a Second Breast Conserving Surgery and Intraoperative Radiotherapy
2689 - Early Results of a Phase II Trial of Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients (UNIQUE)
2690 - Early Results of a Prospective Study of Preoperative Tumor-Bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early-Stage Breast Cancer
2696 - Serial Quality-of-Life Scores Following Ultrahypofractionated Radiotherapy (UHFRT) and Simultaneous Integrated Boost (SIB) Post Breast Conserving Surgery: Largest Real-World Data of a Prospectively Fo
2698 - Development and Validation of a Prediction Model for Major Adverse Cardiac Events in Patients with Hepatocellular Carcinoma Undergoing Stereotactic Body Radiation Therapy
Location: Hall C
Presenter: Hye In Lee, MD – Seoul National University Hospital
3:00 PM - 4:00 PM ET
2699 - Re-Irradiation Toxicity and Survival Outcomes for Locoregionally Recurrent or New Ipsilateral Breast Cancer
2702 - Daily Online Adaptive Radiotherapy with Narrow Margins for Ultra-Hypofractionated Whole Breast Irradiation (A-FF-WBI): Dosimetry and Early Clinical Outcomes
2703 - Diagnostic Value of 18F-FAPI-04 PET/CT for Identification of Benign Breast Lesions and Breast Cancers: Comparison with Traditional Imaging Examinations
2705 - Dosimetric Comparison of Simultaneous Integrated Boost Using Field-in-Field IMRT vs. Hybrid VMAT vs. Ring Gantry VMAT for Left-Sided Breast Cancers
2709 - A New Method for Breast Cancer Classification: Comprehensive Application of Latent Class Analysis in Clinical and Genetic Expression Information
2713 - Cardiac Events and Dynamic Echocardiogram Changes in Low Cardiovascular Risk Patients with Triple Negative Breast Cancer Treated with Immunotherapy
2715 - Preliminary Results of a Phase I Trial Using Preoperative Stereotactic Ablative Breast Radiotherapy (SABER) for Selected Early-Stage Breast Cancer
2719 - The PREDICT II Registry: A Prospective Study to Evaluate the Clinical Utility of a 7-Gene Predictive Biosignature on Treatment Decisions in Patients with Ductal Carcinoma In Situ
2720 - Multi-Institutional Phase II Trial Using Dose Escalated Five Fraction Stereotactic Partial Breast Irradiation (S-PBI) with a Cobalt Stereotactic Unit for Early Stage Breast Cancer
Location: Hall C
Presenter: Asal Rahimi, MD, MS – University of Texas Southwestern Medical Center
3:00 PM - 4:00 PM ET
2721 - Early Outcomes of Accelerated Partial Breast Irradiation with Interstitial Brachytherapy vs. Extreme Hypo-Fractionated EBRT in Indian Females with Early Breast Cancer - A Randomized Controlled Trial
2723 - Complications of Post-Mastectomy Radiotherapy in Immediate Two-Stage Implant Reconstruction: Contemporary Outcomes at an Academic Hospital System
Location: Hall C
Presenter: Matthew Riina, MD – Hospital of the University of Pennsylvania
3:00 PM - 4:00 PM ET
2725 - Partial Breast Radiation Outcomes and Toxicity for Women with Early Breast Cancer in a Large Community Based Practice
2731 - Postoperative Breast Radiation Therapy Using Deformable Image Registration of Initial PET/CT in the Same Posture before Primary Systemic Therapy: Does PET-Based Precise Planning Translate into a Clini
2732 - Evolution of Radiotherapy Options for Elderly Patients with Early Stage ER+ Breast Cancer: A 10 Year Review
Location: Hall C
Presenter: Karin Skalina, MD, PhD – Montefiore Medical Center/Albert Einstein College of Medicine
3:00 PM - 4:00 PM ET
2733 - Large Tumor-Bed Boost Size and Cosmesis after Breast-Conserving Surgery and Whole Breast Irradiation: A Post Hoc Analysis of a Phase III Randomized Trial Comparing Hypofractionated and Conventional Fr
Location: Hall C
Presenter: Yuchun Song, MD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
3:00 PM - 4:00 PM ET
2735 - Evaluation of Cardiac Damage by Cardiac CT in Patients with Esophageal Cancer prior to Radiotherapy
2736 - Adoption of Hypofractionated and Ultrahypofractionated Adjuvant Radiation Therapy for Breast Cancer Treatment among Providers at a Large Academic Medical Center
2738 - A Single-Institution Retrospective Review Intensity-Modulated Accelerated Partial Breast Irradiation Using a Radiopaque Filament and Breath-Hold to Facilitate Reduced CTV to PTV Margin
2739 - Pre-Operative, Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer: Radiology-Pathology Correlation of Tumor Response in a Phase 2 Clinical Trial
2741 - Radiation or Axillary Lymph Node Dissection after Positive Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy for Breast Cancer: A Retrospective Review
Location: Hall C
Presenter: Kathleen Waeldner, BA – Robert Larner, MD College of Medicine at the University of Vermont
3:00 PM - 4:00 PM ET
2742 - Simultaneous Integrated Tumor Bed Boost vs. Sequential Boost during Conventional Fractionated Whole-Breast Irradiation after Breast-Conserving Surgery
Location: Hall C
Presenter: Dan-Qiong Wang, MD – National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade
3:00 PM - 4:00 PM ET
2743 - Simultaneous Integrated Tumor Bed Boost vs. Sequential Boost during Hypofractionated Whole-Breast Irradiation after Breast-Conserving Surgery
Location: Hall C
Presenter: Dan-Qiong Wang, MD – National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade
3:00 PM - 4:00 PM ET
2744 - Study on Short-Term Complications and Quality of Life for Breast Cancer Patients Who Underwent Breast-Conserving Surgery Combined with Intraoperative Radiotherapy
2745 - Dosimetric Benefit and Clinical Feasibility of Deep Inspiratory Breath-Hold and Volumetric Modulated Arc Therapy Based Postmastectomy Radiotherapy for Left-Sided Breast Cancer
2746 - Clinical Outcomes after Post-Operative Radiotherapy for Breast Cancer Patients Presenting with Ipsilateral Supraclavicular Metastasis: Considerations on the Cranial Border of Irradiation Field
2748 - Predicting Radiation-Induced Acute Toxicity in Breast Cancer Patients: A Radiogenomic Approach
Location: Hall C
Presenter: Shouyi Wei – Rutgers Cancer Institute of New Jersey
3:00 PM - 4:00 PM ET
2749 - Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer is Underutilized but Increasing in the National Cancer Database 2010-2021
Location: Hall C
Presenter: Jose Bazan, MD, MS – City of Hope Comprehensive Cancer Center
3:00 PM - 4:00 PM ET
2750 - Thoracic Anatomic Features Predict Benefit from Proton Therapy in Breast Cancer Patients: A Study Based on NTCP Model of Lung Toxicity
2753 - Radiotherapy Quality Assurance of the Ongoing Potential Phase III Randomized Controlled Trial Investigating the Role of Internal Mammary Lymph Node Irradiation for Breast Cancer: An Individual Case Re
Location: Hall C
Presenter: Xuran Zhao, MD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
3:00 PM - 4:00 PM ET
2754 - Cardiac Dose and Injury after Radiotherapy in Patients with Postoperative Left-Sided Breast Cancer: A Cardiac Magnetic Resonance Study
Location: Hall C
Presenter: Jun Yin, MD – Sichuan Cancer Hospital and Institute
3:00 PM - 4:00 PM ET
2755 - Is the Strategy of Regional Nodal Irradiation (RNI) in cT1-2N0M0 Breast Patients with Limited Positive Sentinel Nodes (SLNs) Forgoing ALND Associated with the Risk of Non-SLNs Metastasis: A Multi-Cent
Location: Hall C
Presenter: Siyue Zheng, MD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
3:00 PM - 4:00 PM ET
2756 - Can Surface-Guided Radiation Therapy (SGRT) be Used to Monitor Intrafraction Motion of Patients Receiving Accelerated Partial Breast Irradiation (APBI)?
2768 - Potential Utility of Interim PET CT as Predictive and Prognostic Marker is Locally Advanced Head and Neck Squamous Cell Carcinoma Patients Treated with Simultaneous Integrated Boost-IMRT- Can One Scan
2771 - Comparison of Post Treatment Hematologic Changes between FLASH and Conventional Dose Rate Murine Brain Irradiation
Location: Hall C
Presenter: Khaled Aziz, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
5:00 PM - 6:00 PM ET
2772 - Mechanisms of B-Cell Activity in Tumor Microenvironment
Location: Hall C
Presenter: Khaled Aziz, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
5:00 PM - 6:00 PM ET
2773 - Ginsenoside Rg5 affects irradiation-induced lung fibrosis in mice via macrophage-mediated phagocytosis involving MERTK and PTX3
Location: Hall C
Presenter: Hansong Bai, MD, PhD – Georgetown - Lombardi Cancer Center and Georgetown Medical School
5:00 PM - 6:00 PM ET
2774 - Patient-reported outcomes from an App-delivered Yogic breathing when compared to mindfulness in post-radiation therapy in breast cancer survivors: a randomized controlled trial
2777 - Radiation Enhances the Efficacy of HER2.28?/PD-L1.BB CAR-T Cells Against Triple-Negative Breast Cancer By Increased the Infiltration of CD8+ T Cells into Tumors
2778 - Impact of Survivorship Care Plans (SCPs) on Patients Perceptions of Information Provided from Diagnosis to Follow-Up in Breast Cancer Patients Treated at a Rural Community Cancer Center
2780 - The Association of Genetic Polymorphisms in the TNF-a Gene and Mucositis in Head and Neck Cancer Patients Treated with Combined Radiotherapy and Chemotherapy
2793 - Can Hyperthermia Treatment Restore Sensitivity to Anti-PDL1 Therapy in Immunological Cold Tumors? Lessons Learned from Preclinical Murine Models
Location: Hall C
Presenter: Guanyu Gong, PhD – Affiliated Zhongshan Hospital of Dalian University
5:00 PM - 6:00 PM ET
2794 - AP97-110 Combined with AZD6738 and Radiotherapy Sensitivity of Liver Cancer by Inhibiting XPO1 and ATR
2798 - SWItch/Sucrose NonFermentable Complex-Deficient Pulmonary Neoplasms: Clinicopathologic Characteristics and Outcomes to Radiotherapy and Immunotherapy
2803 - Clonogenic Cell Survival Following In Vitro Irradiation Using Open vs. 2-Dimensional GRID Field Spatially Fractionated Radiotherapy of Murine Lymphoma, Breast and Renal Carcinoma
Location: Hall C
Presenter: Hye Ri Han, MD, MS – University of Southern California/Los Angeles General Medical Center
5:00 PM - 6:00 PM ET
2804 - Efficacy of Fas-4-1BB Immunomodulatory Fusion Proteins Engineered T-Cells in Applying to Targeted Pubic Neoantigen Immunotherapy Using Encapsulated Nanoparticles Directed by Radiation
2813 - Dosimetric Predictors of Dysphonia in Long-Term Survivors of Locally Advanced Head and Neck Cancer Treated with Radiation Therapy
Location: Hall C
Presenter: Adam Hubler, MD – University of Alabama at Birmingham
5:00 PM - 6:00 PM ET
2814 - A Pilot Study to Detect Inflammatory Biomarkers of Pneumonitis in Exhaled Breath during Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Ryan Hughes, MD – Wake Forest University School of Medicine
5:00 PM - 6:00 PM ET
2815 - Urinary Quality of Life in Patients Treated with Prostate SBRT with Intra-Prostatic Boost
2823 - Patient-Derived Pancreatic Tumor Organoids as a Surrogate to Predict Radiation and Chemotherapy Response in Individual Patients: A Model for Precision Medicine
2834 - Prediction of Parotid Gland Changes in Radiation-Induced Oral Mucositis of Nasopharyngeal Carcinoma Based on Metabolism-Imaging Bimodal Omics
Location: Hall C
Presenter: Lei Ji, MD – The First Affiliated Hospital of Soochow University
5:00 PM - 6:00 PM ET
2835 - Exploration of the Effectiveness and Mechanism of Reversal of Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma by High-Energy X-Ray Based FLASH Radiotherapy
2837 - Preliminary Study on Immunological Mechanism of Partial Stereotactic Ablative Boost Radiotherapy (P-SABR)
Location: Hall C
Presenter: Shanshi Li, PhD – Peking University First Hospital
5:00 PM - 6:00 PM ET
2838 - The Circadian Clock Gene, BMAL1, and Radiosensitization in Nasopharyngeal Carcinoma by Inhibiting the Epithelial-to-Mesenchymal Transition via the TGF-ß1/Smads/Snail1 axis
2846 - Old Wine in a New Bottle: The Antimycotic Agent Oxiconazole and PRDX2-Mediated Ferroptosis in NSCLC
Location: Hall C
Presenter: Xu Liu – Shandong Cancer Hospital and Institute
5:00 PM - 6:00 PM ET
2847 - Economic Evaluation of Pediatric Cancer Survivors after Receiving Proton Radiotherapy Compared to Photon Radiotherapy: Real-World Data from 2010-2022
Location: Hall C
Presenter: Natalie Logie, MD – Tom Baker Cancer Centre / University of Calgary
5:00 PM - 6:00 PM ET
2848 - Pulsed vs. Single Shot Immune-Amplified 1Gy Miniscule Radiotherapy Synchronic with Immune-Check Point Inhibitors and SBRT in Disseminated Malignancies-Immuno-Rad(i-RT) Concept to Reprogram Microenviro
2864 - Exploring Quality of Life, and Changes in Sexual Function and Urinary Symptoms in Patients Commencing Combined Hormonal Therapy with Abiraterone Acetate and a GnRH Agonist: A Prospective Study [CTRIAL
Location: Hall C
Presenter: Geraldine Murphy, MD, MB – Princess Margaret Cancer Center, University Health Network
5:00 PM - 6:00 PM ET
2865 - Focused CRISPR Activation-Based Screening to Identify Novel Targets of Chemoradiation Resistance in Pancreatic Cancer
2868 - Changes in Systemic Immune Response and Its Dosimetric Correlates in Patients with Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
2869 - Development of a Multidisciplinary Sexual Health Program (MSHP): A Supportive Care Needs Assessment for Gynecological Cancer Survivors at a Community Hospital
2878 - Using Virtual Reality Technology to Improve Patient Anxiety and Reduce Opioids Use during HDR Brachytherapy Procedure for Patients with Gynecological Cancer
Location: Hall C
Presenter: Santanu Samanta, MD – University of Arkansas for Medical Sciences (UAMS)
5:00 PM - 6:00 PM ET
2879 - Mitophagy Promoting Fasting Diet Positioned Radiation Therapy for Harmonizing Dysregulated Cellular Energetics in Locally Advanced Non Metastatic Cancers: Conceptual Comparative Clinical Application S
2880 - Reduced Gastrointestinal Toxicity with Rectal Spacing in Men Treated with Prostate Stereotactic Body Radiation Therapy and Supplemental Pelvic Intensity Modulated Radiation Therapy
2881 - Biochemical and Biophysical Studies of Novel Small Molecules Targeting Proteasome Subunit Alpha Type-7 (PSMA7) for the Treatment of Glioblastoma
2896 - First Steps toward Prevention of Patchy Alopecia Following Linac Based Fractionated Stereotactic Radiotherapy (fSRT) for Arteriovenous Malformation(AVM): A Retrospective, Single Institutional Experien
2898 - Prospective Longitudinal Study of Quality of Life, Brain Substructure Atrophy, and Neurocognitive Outcomes in Children Following Proton Therapy for Brain Tumors
2917 - Preclinical Evaluation and Pilot Clinical Study of [18F]AlF-NOTA-QHY-04 for PET Imaging of CXCR4 Expression in Hematologic Malignancy and Solid Tumors
2923 - Enhancing Histological Image Analysis and Automation through Unsupervised Attention-Guided Deep Learning for Robust Stain Normalization in H&E-Stained Images
2926 - ILT4, Immunosuppression, and Resistance to Radioimmunotherapy (iRT) in Non-Small Cell Lung Cancer (NSCLC) through Recruiting SHP2 to Induce Mitochondrial Oxidative Stress-Mediated Tumor-Associated Mac
2942 - Toward a Clinical Trial in the Human Liver: Effect of Intralesional Diffusing Alpha Emitters Radiation Therapy on Orthotopic Murine Liver Colorectal Metastasis Growth, Healthy Liver Tissue and Immune
2974 - Salvage Radiotherapy in Isolated Locoregional Recurrence of Pancreatic Adenocarcinoma Post-Radical Surgical Resection: Prudent or Pointless? A Retrospective Comparative Analysis
Location: Hall C
Presenter: Aruz Mesci, MD, PhD – Princess Margaret Cancer Center, University Health Network
5:00 PM - 6:00 PM ET
3186 - Is there an association between the location of the dominant intraprostatic lesion and biochemical/clinical failure following treatment with LDR prostate brachytherapy?